NREP
NEW REPRESENTATIVE AT IB RECEIVED
25/06/2026
Voltar para busca
Dado oficial do USPTO
SEAMLESS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
52
Atualização mais recente
25/06/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 42
Data de depósito
14/12/2023
Data de registro
17/03/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
17/03/2026
Última transação
25/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
DE
Examinador
LIU, PHILIP HUAI-EN
Unidade examinadora
L90
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of the wording "SEAMLESS" in stylized font next to the letter "S" comprised of curved bands.
Titulares e representantes
Titulares
Seamless Therapeutics GmbH
Representantes
Brian J. Focarino COOLEY LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals for use in industry and science; biological preparations and biological chemical reagents for use in industry and science; all of the foregoing used for non-medical purposes
Classe 5
Pharmaceutical and biological preparations for gene therapies and gene-editing therapiesall for the treatment of genetic and viral diseases; medicalpharmaceutical and biopharmaceutical preparations and substances containing programmable recombinases for the treatment of genetic and viral diseases; pharmaceutical goods and preparationsgene transferregulationmodulation and delivery medications for the treatment of genetic and viral diseases and disorders; productsagentsfor medical purposesfor veterinary purposes in the nature of pharmaceutical preparations for cellulargenome and gene editing therapies to treat geneticoncologicalimmune system-relatedinflammatory disorders and diseases; genome editable enzymes being enzymes for medical purposes; DNA recombinant enzymes being enzymes for medical purposes; DNA editable enzymesespeciallyrecombinases and integrases being enzymes for medical purposes; genome editable enzymes for the treatment of diseases being enzymes for medical purposes; DNA recombinant enzymes for the treatment of diseases being enzymes for medical purposes; DNA editable enzymesin particular recombinases and integrasesfor the treatment of diseases being enzymes for medical purposes
Classe 42
Scientific and technological servicesproduct research and testing of pharmaceuticals for cell and gene therapies in the field of pharmaceutical product development for the creation of bioinformatic algorithms and models; development of pharmaceutical preparations and medicinesnone of the foregoing for diagnostics; pharmaceutical product developmentnone of the foregoing for diagnostics; pharmaceutical products development of genome editable enzymes for treatment and not diagnostic purposes; pharmaceutical products development of DNA editable enzymesin particular recombinases and integrasesfor treatment and not diagnostic purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
52 publicações encontradas
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
17/06/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
19/03/2026
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
19/03/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
19/03/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
19/03/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
17/03/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
17/03/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
29/01/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
27/01/2026
PUBO
PUBLISHED FOR OPPOSITION
27/01/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
21/01/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
14/01/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
14/01/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
30/12/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
30/12/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
30/12/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
30/12/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
30/12/2025
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
30/12/2025
EXPT
EXPARTE APPEAL TERMINATED
22/12/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
22/12/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
22/12/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
22/12/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
22/12/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
22/12/2025
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
22/12/2025
GEA1
NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
10/11/2025
GECD
ACTION DENYING REQ FOR RECON E-MAILED
10/11/2025
CNCF
ACTION CONTINUING FINAL - COMPLETED
10/11/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/10/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/10/2025
ALIE
ASSIGNED TO LIE
27/10/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
20/10/2025
EXPI
EX PARTE APPEAL-INSTITUTED
20/10/2025
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
20/10/2025
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
20/10/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
19/04/2025
GNFR
FINAL REFUSAL E-MAILED
19/04/2025
CNFR
FINAL REFUSAL WRITTEN
19/04/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/03/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/03/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/03/2025
RFNT
REFUSAL PROCESSED BY IB
30/09/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/09/2024
RFRR
REFUSAL PROCESSED BY MPU
07/09/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/09/2024
CNRT
NON-FINAL ACTION WRITTEN
03/09/2024
DOCK
ASSIGNED TO EXAMINER
22/08/2024
MAFR
APPLICATION FILING RECEIPT MAILED
21/08/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
21/08/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
15/08/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SEAMLESS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.